KRAS and pancreatic neoplasm: In vivo, an acinar cell-specific knockout of PKD1 significantly decreased the formation and progression of KRas-induced precancerous lesions18; and an inhibition of PKD decreased orthotopic growth of pancreatic tumor cell lines in mice22.